Tratamiento del carcinoma de pulmón de células no pequeñas: visión crítica de nuestra experiencia
Puyol, Jorge; Podestá, Eduardo; Maldonado, Daniel; Pazos, Claudia; Jovtis, Silvia; Morera, Federico.
Rev. argent. cancerol
; 22(3): 159-60, 162-4, 166-8, 1994. tab
Artículo en Español | BINACIS | ID: bin-23226
Documentos relacionados
[Advances in the application of aberrant DNA methylation in the diagnosis and treatment of lung cancer].
Acquiring tissue for advanced lung cancer diagnosis and comprehensive biomarker testing: A National Lung Cancer Roundtable best-practice guide.
[Opportunities and challenges in accurate early diagnosis and treatment of lung cancer/pulmonary nodules].
[Treatment in Certified Centres (DKG): Decision Factors of Lung Cancer Patients].
Development and Update of Guideline-based Quality Indicators in Lung Cancer.
The Spectrum of Infections in Patients with Lung Cancer.
Deciphering a cell death-associated signature for predicting prognosis and response to immunotherapy in lung squamous cell carcinoma.
European Respiratory Society guideline on various aspects of quality in lung cancer care.
[Chinese expert consensus: multidisciplinary diagnosis and treatment of multiple ground-glass nodule like lung cancer (2024 edition)].
Cancer care reform in South Africa: A case for cancer care coordination: A narrative review.